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SUMMARY.-Platinum diamine dichloride and tetrachloride inhibit the
formation ofantibody-forming cells in the mouse spleen after injection ofsheep
red cells. The dichloride is the more effective agent. It acts best when given
2 days after the antigen, which suggests that cells are more sensitive to its
action when they are rapidly proliferating than when they are resting. Its
dose-response curve is exponential,suggesting that its action is like that of an
alkylating agent. Platinum ethylene diamines were relatively ineffective in
this system.
RoSENBERG, VAN CAMP AND KRIGAS (1965), while investi-aatina the effects of
electric currents on bacteria, found that bacterial division was inhibited when
platinum electrodes were used. Further investigations showed that this effect
was due to the formation of small amounts ofplatinum diamines, which entered
the bacteria and became associated with intermediary metabolites, nucleic acids
and cytoplasmic protein (Rosenberg, Van Camp, Grimley and Thomson, 1967;
Renshaw andThomson, 1967). Recently it has been found that these compounds
inhibit the growth of transplantable mouse tumours (Rosenberg, Van Camp,
Trosko and Mansour, 1969; Rosenberg and Van Camp, 1970; Talley, 1970).
The mechanism of action ofplatinum diamines is obscure at present, although
it is known that they inhibit DNA synthesis (Howle and Gale, 1970). Since they
form complexes with nucleic acids, their cellular effects might resemble those of
thealkylating agents andradiation, whichdirectlydamage this material. On the
other hand, if their complexing with intermediary metabolites is important, they
could act as antimetabolites. It was therefore of interest to examine the effects
ofthese agents on mouse antibody-forming cells, as this system lends itselfreadily
to studies ofdose-response relations and oftime-dependent effects, both of which
may throw light on the modes of action of cytotoxic agents at the cellular level.
MATERIALS AND METHODS
Male BALB/c mice, weighing 17-21 g. at the start of the experiment, were
given 0-2 ml. of 10 per cent formolized sheep red cells intravenously. Two days
later, various doses ofplatinum diamines suspended in 5 per cent carboxymethyl
cellulose (25 CPS, Dow Chemical Company) in saline were given intraperitoneally.
On the fifth day after the antigen injection, the numbers of direct haemolytic
plaque-forming cells per spleen were determined (Jerne and Nordin, 1963).
Thetime-dependence oftheimmunosuppressive effect ofplatinum (11) diamine
dichloride was determinedbygiving either 10 or 20 mg./kg. on variousdays before209 IMMUNOSUPPRESSION BY PLATINUM DIAMINES
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FIG. I.-Dose-response curves for inhibition of formation of plaque-producing cells (PFC) by
platinum diamines. Sheep red cells given on day 0 and various doses of drug on day +2.
PFC counted on day +5. The points show the geometric means and log standard
deviations in groups of 6 mice.
U)
0
-41.1
c
0
u
.+-- 1.0 0
c
0
-I--,
u
p
c
a)
w
a
co
u 0.1
U-
0-
c -3 -2 -1 0 +1
Day of drug injection
+2 +3
YiG. 2.-Time-dependence ofimmunosuppression byplatinum (II) diamine dicworide. Sheel)
red cells given on day 0 and a single injection of drug (10 or 20 mg./kg.) on day 3 to day
+3. PFC counted on day +5. The points show the geometric means and log standard
deviations in groups of 6 mice. C-controls.210 M.C.BERENBAUM
or after an injection ofsheep red cells, and counting plaque-forming cells on the
fifth day.
RESULTS
The dose-response curves of the various agents are shown in Fig. 1. It is
seenthatthe mosteffectiveagentisplatinumJI)diaminedichloride[Pt(NH3)2Cl21,
followed by platinum (IV) diamine tetrachloride [Pt(NH3)2C'41. The platinum
ethylene diamines [Pt-en-Cld and [Pt-en-C'41 were almost completely ineffective
in the doses used. Platinum JI) diamine dichloride shows the best defined
dose-response curve. This is an exponential curve with a D37 of 3-5 mg./kg. and
an extrapolation number of 1-5.
Thetime-dependence ofthe effects ofplatinum (11) diamine dichloride is shown
in Fig. 2. The time of maximum sensitivity of immunologically active cells to
this agent is 2 days after administration of antigen; administration before or
simultaneously with the antigen is ineffective.
DISCUSSION
The exponentialdose-response curvegivenbyplatinum JI) diamine dichloride
suggests a random
" hit
" mode ofaction, as similar curves are given by ionizing
radiation and alkylating agents. By contrast, agents that act competitively such
as antimetabolites, or enzymes that deplete natural metabolites, tend to give
hyperbolic dose-response curves (Berenbaum, 1969, 1970, 1971). The time-
dependence of the immunosuppressive effect ofplatinum JI) diamine dichloride
suggests that it is particularly toxic to rapidly proliferating cells and that resting
cells are relatively insensitive to its action. A similar time-dependence is shown
by most alkylating agents and antimetabolites, but notby radiation (Berenbaum,
1967).
These agents arehighly toxic in the doses used here. Forexample, 10 mg./kg.
of the diamine dichloride, which reduces plaque-forming cells to about 0-1 of
control levels, kills 20 per cent of mice (Rosenberg and Van Camp, 1970). This
should be compared with cyclophosphamide, which reduces plaque-forming cells
to 0-001 of control levels at doses far below the LD-0. It is possible that the
unique effectiveness of the platinum (11) diamine dichloride in causing complete
regression oflarge, solid sarcoma 180 tumours in random-bred mice (Rosenberg
and VanCamp, 1970) ispartly due to the relative feebleness ofitsimmunosuppres-
sive activity, which fails to interfere effectively with immune responses in the
tumour-bearing host.
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